zilucoplanCOVID-19NCT04225871NCT04115293
… study, 93 continued zilucoplan and 90 switched from placebo to zilucoplan. At Week 120, mean CFB in MG-ADL score in pooled zilucoplan 0.3…
3articles mentioning drugs
19drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: zilucoplan ×
zilucoplan
This drug is selected. Its supporting articles are shown below.
Articles mentioning zilucoplan
3 articles · page 1 of 1zilucoplanMyasthenia GravisUCB
…Background In RAISE ( NCT04115293; Phase 3 study), zilucoplan, a macrocyclic peptide complement component 5 inhibitor, demons…
rozanolixizumabZilucoplanIVIgNICEplasma exchangegMGPLEX
… support time in England over 5 years.Conclusion Zilucoplan and rozanolixizumab are associated with staff and patient time savings by potential…